Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Avivagen Inc V.VIV

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Major
Alternate Symbol(s):  CHEXF

Avivagen Inc is a development-stage company. The Company develops small-molecule compound discoveries for commercialization in markets in distinct biotechnology sectors.
Price: $0.06 | Change: $0.00 | %Change: 0.00%
Volume: 0 | Day High/Low: N/A/N/A | 52 Week High/Low: 0.10/0.055


Last Traded: September 18, 2014 06:57 Transaction Volume: 0
Open: $0.06 Previous Close: $0.06
Bid: $0.06 Ask: $0.065
Bid Size: 93,000 Ask Size: 79,000
Market Cap: $10.3m Shares Out: 171.4m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest Bullboard Posts

  • RE:info needed

    2 stars

    No reply from company unfortunatley, I guess we wait and hope for some type of a news release and hopefully something soon. Not looking...

    3.5 stars

  • RE:RE:info needed

    5 stars

    What news releases are expected before year end, I seem to have a hard time findinding when we should expexct results from the trials. I...

    3.5 stars

  • RE:info needed

    5 stars

    1st Publication on OxC‐beta (Feb. 2014) • Vietnam swine trial started (Mar. 2014) • Korea poultry trial started (Mar. 2014...

    4 stars

  • info needed

    0 stars

    I have left a message looking to see if results for the swine trials are on track for Q4 and looking for more info and due dates for the...

    3.5 stars

  • Volume

    3 stars

    Well it is nice to see some one has taken a 37K interest in the company and some shares moving. As every one else I am excited to hear...

    2 stars